biomedicina slovenica


pr=Čučnik : 101-200

  1. Ogrič Manca; Terčelj Matic; Praprotnik Sonja; Tomšič Matija; Božič Borut; Sodin-Šemrl Snežna; Čučnik Saša
    Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis
    2017
  2. Kuret Tadeja; Lakota Katja; Žigon Polona; Ogrič Manca; Rotar Žiga; Ješe Rok; Sodin-Šemrl Snežna; Čučnik Saša; Tomšič Matija; Hočevar Alojzija
    Neutrophils in giant cell arteritis
    2017
  3. Lakota Katja; Feichtinger J.; Burja Blaz; Kuret Tadeja; Žigon Polona; Rotar Žiga; Ješe Rok; Sodin-Šemrl Snežna; Čučnik Saša; Thallinger Gerhard G.; Tomšič Matija; Hočevar Alojzija
    Utility of serological parameters in giant cell arteritis for predicting disease complications
    2017
  4. Ogrič Manca; Žigon Polona; Praprotnik Sonja; Drobne David; Štabuc Borut; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Stability of infliximab under different storage conditions used as a standard for in-house infliximab ELISA
    2017
  5. Hočevar Alojzija; Ostrovršnik Jaka; Žigon Polona; Čučnik Saša; Rotar Žiga; Tomšič Matija
    Antiphospholipid antibodies in adult IGA vasculitis
    2017
  6. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Antiphospholipid antibodies in association to adverse pregnancy outcome
    2016
  7. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Antiprothrombin antibodies in the diagnosis of APS
    2016
  8. Ogrič Manca; Žigon Polona; Praprotnik Sonja; Drobne David; Štabuc Borut; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    The impact of different storage conditions on original or biosimilar infliximab used as a standard in in-house infliximab ELISA
    2016
  9. Ogrič Manca; Žigon Polona; Praprotnik Sonja; Drobne David; Štabuc Borut; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Comparison and evaluation of two commercial assays for infliximab detection with an in-house infliximab enzyme-linked immunosorbent assay
    2016
  10. Ogrič Manca; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Imunogenost zaviralcev dejavnika tumorske nekroze alfa
    [Immunogenicity of tumour necrosis factor alpha inhibitors]
    2016
  11. Perdan-Pirkmajer Katja; Boc Anja; Čučnik Saša; Mavri Alenka; Žigon Polona; Štalc Monika; Vene Nina; Ambrožič Aleš
    The predictive value of Acl and anti-[beta]2GPI in patients with acute deep vein thrombosis
    2016
  12. Burja Blaz; Lakota Katja; Kuret Tadeja; Žigon Polona; Ješe Rok; Tomšič Matija; Rotar Žiga; Praprotnik Sonja; Švec Tinka; Čučnik Saša; Sodin-Šemrl Snežna; Hočevar Alojzija
    Utilization of Multiple Acute Phase Proteins and Biomarkers for Giant Cell arteritis - insight into diagnosis and clinical complications
    2016
  13. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Association of Conventional Risk Factors and Antiphospholipid Antibodies to thrombosis in patients with autoimmune diseases
    2016
  14. Hočevar Alojzija; Ostrovršnik Jaka; Žigon Polona; Čučnik Saša; Rotar Žiga; Tomšič Matija
    Antiphospoholipid antibodies in adult iga vasculitis
    2016
  15. Hočevar Alojzija; Ješe Rok; Rotar Žiga; Žigon Polona; Čučnik Saša; Tomšič Matija
    Antiphospoholipid antibodies in giant cell arteritis. What can they tell us?
    2016
  16. Hočevar Alojzija; Ješe Rok; Rotar Žiga; Žigon Polona; Čučnik Saša; Tomšič Matija
    Pomen antifosfolipidnih avtoprotiteles pri gigantoceličnem arteriitisu
    2016
  17. Žigon Polona; Mrak Poljšak Katjuša; Lakota Katja; Terčelj Matic; Čučnik Saša; Tomšič Matija; Sodin-Šemrl Snežna
    Metabolic fingerprints of human primary endothelial and fibroblast cells
    2016
  18. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometric immunoassay for detection of anti-dsDNA antibodies
    [Dosage immunologique fluorométrique pour la détection d'anticorps anti-adndb]
    2015
  19. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Thrombotic risk factors and global antiphospholipid syndrome score (gapss) as determined in 585 slovenian patients with systemic autoimmune diseases
    2016
  20. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Added value of anti-phosphatidylserine/prothrombin antibodies for antiphospholipid syndome
    2016
  21. Čučnik Saša
    Imunokemijske značilnosti klinično pomembnih protiteles [beta]2-glikoproteinu I
    [Immunochemical properties of clinically relevant anti-[beta]2-glycoprotein I antibodies]
    2016
  22. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    IGA antiphospholipid antibodies present a thrombotic risk in patients with systemic autoimmune diseases
    2016
  23. Žigon Polona; Lakota Katja; Kuret Tadeja; Tomšič Matija; Čučnik Saša; Sodin-Šemrl Snežna; Hočevar Alojzija
    Acute phase proteins and interleukin-6 are important in distinguishing between giant cell arteritis positive and negative patients
    2016
  24. Čučnik Saša
    Novosti v serološki diagnostiki polimiozitisov in dermatomiozitisov
    2016
  25. Čučnik Saša
    Testiranje imunogeničnosti kod bolesnika sa reumatoidnim artritisom u remisiji
    2016
  26. Hočevar Alojzija; Rotar Žiga; Jurčić Vesna; Pižem Jože; Čučnik Saša; Vizjak Alenka; Broeke Rianne; Tomšič Matija
    IgA vasculitis in adults
    2016
  27. Flašker Ajda; Kulkarni Mukta Vishwanath; Mrak Poljšak Katjuša; Junkar Ita; Čučnik Saša; Žigon Polona; Mazare Anca; Schmuki Patrik; Iglič Aleš; Sodin-Šemrl Snežna
    Binding of human coronary artery endothelial cells to plasma-treated titanium dioxide nanotubes of different diameters
    2016
  28. Hočevar Alojzija; Rotar Žiga; Jurčić Vesna; Čučnik Saša; Tomšič Matija
    Patient age, gender and extent of purpura may suggest short-term outcomes in adults with IgA vasculitis
    2015
  29. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    Laboratory diagnostics of APS and future perspectives
    2015
  30. Jenko Barbara; Praprotnik Sonja; Čučnik Saša; Rotar Žiga; Tomšič Matija; Dolžan Vita
    Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients
    2016
  31. Žigon Polona; Čučnik Saša; Ambrožič Aleš; Sodin-Šemrl Snežna
    Diagnostic efficacy of antiphosphatidylserine/prothrombin antibodies (aPS/PT) for antiphospholipid syndrome
    2012
  32. Hočevar Alojzija; Ješe Rok; Rotar Žiga; Praprotnik Sonja; Tomšič Matija; Čučnik Saša
    Can we predict the relapse of giant cell arteritis?
    2015
  33. Lakota Katja; Kuret Tadeja; Žigon Polona; Rotar Žiga; Tomšič Matija; Čučnik Saša; Sodin-Šemrl Snežna; Hočevar Alojzija
    Biomarkers in temporal artery biopsies and sera of patients with giant cell arteritis
    2015
  34. Lakota Katja; Hrušovar Dolores; Mrak Poljšak Katjuša; Žigon Polona; Čučnik Saša; Božič Borut; Tomšič Matija; Sodin-Šemrl Snežna
    Comparative analysis of drug effects on primary human coronary artery endothelial cells activated by serum amyloid a
    2015
  35. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
    2015
  36. Žigon Polona; Božič Mojca; Frank Mojca; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Božič Borut; Sodin-Šemrl Snežna; Kveder Tanja; Čučnik Saša
    Laboratory methodology important in the diagnosis and prognosis of antiphospholipid syndrome
    2015
  37. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
    2015
  38. Žigon Polona; Mrak Poljšak Katjuša; Čučnik Saša; Terčelj-Zorman Marjeta; Lakota Katja; Milavec Žmak Petra; Štravs Rok; Sodin-Šemrl Snežna
    Metabolic fingerprints of human primary endothelial and fibroblast cells
    2015
  39. Božič Borut; Černe Darko; Pajič Tadej; Homšak Evgenija; Čučnik Saša
    Delovanje komisije za specializacije po letu 2006
    2014
  40. Holc Iztok; Hojs Radovan; Čikeš Nada; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž; Pahor Artur
    Zgodnja ateroskleroza in revmatoidni artritis
    2010
  41. Kulkarni Mukta Vishwanath; Mrak Poljšak Katjuša; Flašker Ajda; Mazare Anca; Schmuki Patrik; Kos Andrej; Čučnik Saša; Sodin-Šemrl Snežna; Iglič Aleš
    Fabrication of TiO[sub]2 nanotubes for bioapplications
    [Izdelava TiO[spodaj]2-nanocevk za biomedicinsko uporabo]
    2015
  42. Gužič-Salobir Barbara; Terčelj Milan; Mlakar Polona; Toplišek Janez; Ambrožič Aleš; Čučnik Saša; Sodin-Šemrl Snežna
    Serum amyloid a is associated with chronic inflammation and markers of disease severity in adult patients with pulmonary hypertension
    2015
  43. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    IgA anti-phosphatidylserin/prothrombin antibodies present a thrombotic risk in patients with systemic autoimmune diseases
    2015
  44. Gašperšič Nataša; Zaletel Marjan; Kobal Jan; Žigon Polona; Čučnik Saša; Sodin-Šemrl Snežna; Tomšič Matija; Ambrožič Aleš
    Antiphospholipid antibodies in patients with cerebrovascular events
    2015
  45. Lakota Katja; Šubelj Vesna; Čučnik Saša; Perdan-Pirkmajer Katja; Sodin-Šemrl Snežna; Prosenc Katarina; Tomšič Matija; Ambrožič Aleš
    The influence of seasonal influenza vaccination on immunogenicity in patients with rheumatoid arthritis
    2015
  46. Žigon Polona; Ambrožič Aleš; Božič Borut; Čučnik Saša
    Protitelesa proti protrombinu
    [Antiprothrombin antibodies]
    2015
  47. Orešnik Špela; Čučnik Saša; Sodin-Šemrl Snežna
    Optimizacija modela celjenja poškodbe monoplastne kulture primarnih humanih pljučnih fibroblastov
    [Optimization of the wound healing model for primary human lung fibroblast monolayer culture]
    2014
  48. Hočevar Alojzija; Rotar Žiga; Jurčić Vesna; Pižem Jože; Čučnik Saša; Vizjak Alenka; Tomšič Matija
    Are EULAR/Printo/PRES classification criteria appropriate for classification of IgA vasculitis in adults?
    2014
  49. Žigon Polona; Perdan-Pirkmajer Katja; Tomšič Matija; Kveder Tanja; Božič Borut; Sodin-Šemrl Snežna; Čučnik Saša; Ambrožič Aleš
    Anti-phosphatidylserine/prothrombin antibodies are associated with adverse pregnancy outcomes
    2015
  50. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometric immunoassay for detection of anti-dsDNA antibodies
    2015
  51. Artenjak Andrej; Omersel Jasna; Ahlin Grabnar Pegi; Mlinarič-Raščan Irena; Shoenfeld Yehuda; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Oxidatively altered IgG with increased immunoreactivity to [beta]2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells
    2015
  52. Kulkarni Mukta Vishwanath; Flašker Ajda; Lokar Maruša; Mrak Poljšak Katjuša; Mazare Anca; Artenjak Andrej; Čučnik Saša; Kralj Slavko; Velikonja Aljaž; Schmuki Patrik; Kralj-Iglič Veronika; Sodin-Šemrl Snežna; Iglič Aleš
    Binding of plasma proteins to titanium dioxide nanotubes with different diameters
    2015
  53. Artenjak Andrej; Locatelli Igor; Brelih Hana; Simonič Darka Maša; Ulčová-Gallová Zdenka; Swadzba J; Musial J; Iwaniec T; Stojanović Ljudmila; Conti F.; Valesini Guido; Avčin Tadej; Cohen Tervaert JW; Shoenfeld Yehuda; Blank Miri; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Immunoreactivity and avidity of IgG anti-ß2- glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of ß2-glycoprotein I
    2014
  54. Žager Urška; Kveder Tanja; Čučnik Saša; Božič Borut; Lunder Mojca
    Anti-ß2-glycoprotein I paratopes and ß2-glycoprotein I epitopes characterization using random peptide libraries
    2014
  55. Čučnik Saša
    Binding properties of clinicaly relevant anti-B2-glycoprotein I antibodies
    2011
  56. Artenjak Andrej; Brelih Hana; Kveder Tanja; Avčin Tadej; Rozman Blaž; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Immunoreactivity of sera from patients with autoimmune diseases to different peptide clusters of beta2-glycoprotein I
    2014
  57. Žigon Polona; Perdan-Pirkmajer Katja; Čučnik Saša; Ambrožič Aleš; Tomšič Matija; Kveder Tanja; Sodin-Šemrl Snežna; Božič Borut
    Anti-annexin v and anti-phosphatidyserine/prothrombin antibodies could indicate additional patients with adverse pregnancy outcomes characteristic for APS
    2014
  58. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Kveder Tanja; Božič Borut; Sodin-Šemrl Snežna; Čučnik Saša
    Anti-beta2-glycoprotein I IGA antibodies present thrombotic risk in patients with systemic autoimmune diseases
    2014
  59. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorescenčna imunska metoda za določamje protiteles proti dvojnoverižni DNA
    2014
  60. Prebil Jasna; Anderluh Gregor; Božič Bojan; Čučnik Saša; Derganc Jure; Majhenc Janja; Rozman Blaž; Svetina Saša
    Binding of [beta]2-glycoprotein I to phospholipid vesicles and its effect on their shape
    2007
  61. Žigon Polona; Čučnik Saša; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Sodin-Šemrl Snežna; Kveder Tanja
    Prevalence of autoantibodies against a second extracellular loop of M3 muscarinic acetylcholine receptor in Sjögren's syndrome
    2014
  62. Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Affinity and avidity of autoantibodies
    2014
  63. Čučnik Saša; Božič Borut
    Clinical relevance of anti-[beta]2-glycoprotein I antibodies binding
    2013
  64. Žigon Polona; Perdan-Pirkmajer Katja; Čučnik Saša; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Kveder Tanja; Božič Borut
    Antiphosphatidylserine/prothrombin antibodies could improve evaluation of patients with obstetric complications characteristic for antiphospholipid syndrome
    2013
  65. Artenjak Andrej; Koželj Mateja; Lakota Katja; Čučnik Saša; Božič Borut; Sodin-Šemrl Snežna
    Activation of human endothelial cells by high avidity anti-[beta]2-glycoprotein I antibodies triggers the migration of monocytes and is intensified in conditions with elevated serum amyloid A
    2013
  66. Artenjak Andrej; Leonardi Adrijana; Križaj Igor; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Optimization of unnicked ß2-glycoprotein I and high avidity anti-ß2-glycoprotein I antibodies isolation
    2014
  67. Žigon Polona; Perdan-Pirkmajer Katja; Čučnik Saša; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Kveder Tanja; Božič Borut
    Anti-phosphatidylserine/prothrombin antibodies are associated with adverse pregnancy outcomes and could provide an additional marker for the diagnosis of APS patients
    2013
  68. Artenjak Andrej; Čučnik Saša; Sodin-Šemrl Snežna; Božič Borut
    Oxidatively altered IgG immunoglobulins react to beta2-glycoprotein I and peptide clusters on beta2-glycoprotein I and influence differential endothelial cell responses
    2013
  69. Artenjak Andrej; Koželj Mateja; Lakota Katja; Čučnik Saša; Božič Borut; Sodin-Šemrl Snežna
    High avidity anti-beta2-glycoprotein I antibodies activate human coronary artery endothelial cells via ERK signaling pathway and trigger migration of monocytes
    2013
  70. Artenjak Andrej; Koželj Mateja; Lakota Katja; Čučnik Saša; Božič Borut; Sodin-Šemrl Snežna
    High avidity anti-[beta]2-glycoprotein i antibodies activate human coronary artery endothelial cells and trigger peripheral blood mononuclear cell migration
    2013
  71. Artenjak Andrej; Kveder Tanja; Ulčová-Gallová Zdenka; Swadzba J; Musial J; Iwaniec T; Stojanović Ljudmila; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Avidity of anti-beta2-glycoprotein i antibodies in patients with antiphospholipid syndrome
    2013
  72. Artenjak Andrej; Čučnik Saša; Božič Borut; Sodin-Šemrl Snežna
    High avidity anti-B2-glycoprotein I antibodies influence monocyte chemoattractant protein-1 and interleukin-6 levels in human coronary artery endothelial cells
    2013
  73. Žigon P; Čučnik S; Ambrožič A; Sodin-Šemrl S; Kveder T; Božič B
    Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?
    2012
  74. Ambrožič Aleš; Božič Borut; Čučnik Saša; Gašperšič Nataša; Hočevar Alojzija; Huzjan Barbka; Jevtič Vladimir; Katelic-Klasinc Cvetka; Kos-Golja Jelka; Kveder Tanja; Lestan Boris; Logar Dušan; Perdan-Pirkmajer Katja; Plešivčnik-Novljan Martina; Praprotnik Sonja; Rainer Saša; Rotar Žiga; Rozman Blaž; Šipek-Dolničar Alenka; Tomšič Matija; Žlebič Jože
    Revmatološki priročnik za družinskega zdravnika
    2012
  75. Žigon P; Čučnik S; Ambrožič A; Sodin-Šemrl S; Kveder T; Božič B
    Antibodies to phosphatidylserin/prothrombin complex as an additional diagnostic marker of APS? (PA15)
    2011
  76. Čučnik S; Kveder T; Artenjak A; Avčin T; Rozman B; Božič B
    3rd report on APL forum project avidity of anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome (2005-2011) (OFP05)
    2011
  77. Čučnik S; Kveder T; Artenjak A; Ulcova-Gallova Z; Swadzba J; Musial J; Iwaniec T; Avčin T; Rozman B; Božič B
    Avidity of anti-beta2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    2012
  78. Artenjak Andrej; Lakota Katja; Frank Mojca; Čučnik Saša; Rozman Blaž; Božič Borut; Shoenfeld Yehuda; Sodin-Šemrl Snežna
    Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review
    2012
  79. Janša Rado; Čučnik Saša; Ambrožič Aleš; Rozman Blaž; Kralj-Iglič Veronika
    Impact of antiphospholipid antibodies on mediated interaction between membranes - a microvesiculation-suppression effect
    2012
  80. Čučnik Saša
    Immunochemical properties of clinically relevant antibodies against beta-2-glycoprotein I of different avidity
    2012
  81. Žigon P; Čučnik S; Ambrožič A; Sodin-Šemrl S; Kveder T; Božič B
    Diagnostic value and avidity of antibodies to phosphatidylserine/prothrombin complex
    2012
  82. Žager U; Lunder M; Čučnik S; Kveder T; Rozman B; Božič B
    Immunodominant epitopes of beta2-glycoprotein I for high avidity antibodies
    2012
  83. Artenjak A; Koželj M; Čučnik S; Sodin-Šemrl S; Božič B
    Optimization of isolation of unnicked beta2-GPI and high avidity anti-beta2-GPI antibodies for further experimental and diagnostic use
    2012
  84. Omersel J; Žager U; Čučnik S; Kveder T; Anderluh G; Sodin-Šemrl S; Rozman B; Božič B
    Oxidation of natural antibodies results in autoimmune reactivity - mew insights into binding characteristics
    2012
  85. Lakota Katja; Thallinger Gerhard G; Sodin-Šemrl Snežna; Rozman Blaž; Ambrožič Aleš; Tomšič Matija; Praprotnik Sonja; Čučnik Saša; Mrak-Poljšak Katjuša; Kveder Tanja
    International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
    2012
  86. Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Šemrl S; Ambrožič A
    Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease
    2012
  87. Lakota Katja; Artenjak Andrej; Čučnik Saša; Brguljan-Hitij Jana; Čegovnik Borut; Salobir Barbara; Accetto Rok; Božič Borut; Rozman Blaž; Sodin-Šemrl Snežna
    Atherogenesis, inflammation and autoimmunity - an overview
    2011
  88. Žigon Polona; Lakota Katja; Čučnik Saša; Švec Tinka; Ambrožič Aleš; Sodin-Šemrl Snežna; Kveder Tanja
    Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients' and blood donors' sera
    2011
  89. Žager U; Lunder M; Hodnik V; Anderluh G; Čučnik S; Kveder T; Rozman B; Božič B
    Characterization of clinically relevant antibodies against ß2-glycoprotein I
    2011
  90. De Laat B; Derksen RHWM; Reber G; Musial J; Swadzba J; Božič B; Čučnik S; Regnault V; Forastiero R; Woodhams BJ
    An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies
    2011
  91. Čučnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avčin T; Rozman B; Božič B
    Avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies
    2011
  92. Žigon Polona; Ambrožič Aleš; Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Modified phosphatidylserine-dependent antiprothrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies
    2011
  93. Lakota Katja; Thallinger Gerghard G; Čučnik Saša; Božič Borut; Mrak-Poljšak Katjuša; Ambrožič Aleš; Rozman Blaž; Blinc A; Tomšič Matija; Sodin-Šemrl Snežna
    Could antibodies against serum amyloid A function as physiological regulators in humans?
    2011
  94. Zager U; Lunder M; Čučnik S; Štrukelj B; Kveder T; Rozman B; Božič B
    Binding cgaracteristics of anti-beta2GPI paratopes revealed by phage display
    2010
  95. Toplak Nataša; Šubelj Vesna; Kveder Tanja; Čučnik Saša; Prosenc Katarina; Trampuš-Bakija Alenka; Avčin Tadej
    Safety and efficacy of influenza vaccination in children with juvenile idiopathic arthritis
    2010
  96. Žigon P; Ambrožič A; Čučnik S; Božič B; Kveder T; Rozman B
    Only aPS/PT ELISA detects low avidity antiprothrombin antibodies
    2010
  97. Toplak N; Kveder T; Čučnik S; Trampuš-Bakija A; Avčin T
    Autoimmune response following influenza vaccination in children with juvenile idiopathic arthritis
    2010
  98. Lakota K; Sodin-Šemrl S; Rozman B; Ambrožič A; Tomšič M; Praprotnik S; Čučnik S; Kveder T
    International cohort study of 72 anti-Ku positive patients with different connective tissue diseases. Profiles of anti-Ku P70 and/or P80 antibodies
    2010
  99. Omersel J; Čučnik S; Avberšek-Lužnik I; Kveder T; Rozman B; Božič B
    Oxidation of antibodies as a trigger for autoimmunity
    2010
  100. Omersel J; Jurgec I; Čučnik S; Kveder T; Rozman B; Sodin-Šemrl S; Božič B
    Autoimmune and proinflammatory activity of oxidized antibodies
    2007

   1 101 201 301  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics